Table 2 Baseline demographic and clinical parameters

n

36

16

8

4

4

Female

13 (36)

4 (25)

2 (25)

1 (25)

1 (25)

Visiting friends and relatives

10 (28)

5 (31)

3 (38)

1 (25)

1 (25)

Traveling from sub-Saharan Africa

35 (97)

16 (100)

8 (100)

4 (100)

4 (100)

ICU treatment

25 (69)

12 (75)

6 (75)

4 (100)

2 (50)

Deaths

1 (3)

0 (0)

0 (0)

1 (25)

0 (0)

Hospital stay duration in days, median (IQR)

10 (7–18)

17 (9–30)

19 (11–30)

17 (4–46)

11 (6–16)

Age in years, median (IQR)

49 (35–55)

48 (37–57)

42 (35–48)

55 (41–59)

54 (28–62)

Temperature in °C

38.1 (37.5-38.6)

38.1 (37.6 – 38.6)

38.2 (37.4- 39.0)

37.1 (37.0 – 37.2)

38.5 (37.6 – 39.4)

Parasitaemia in%, median (IQR)

15 (7–25)

15 (7–24)

12 (5–15)

33 (26–39)

17 (8,-21)

Hb (g/dl, normal range:12.0-16.0 )

11.4 (10.2-12.5)

11.4 (10.0 – 12.9)

11.9 (9.4-14.3)

9.8 (6.4-13.1)

12.3 (7.7-16.9)

WBC (1000/μl, normal range: 3.5 – 10.5)

6.9 (5.4-8.4)

8.1 (5.3-10.9)

7.8 (4.6-11.0)

11.6 (0.0-24.8)

5.5 (1.1-9.9)

Creatinine (mg/dl, normal range: 0.6 – 1.3)

1.6 (1.0-2.2)

2.0 (1.3-2.8)

2.0 (0.7-3.3)

1.7 (0.0-3.6)

2.5 (0.6-4.4)

Bilirubin (mg/dl, normal range: <1.2)

4.0 (2.7-5.2)

5.0 (3.9-6.1)

4.9 (3.0-6.8)

4.2 (0.0-10.3)

5.9 (3.3-8.5)

GOT (U/l, normal range: <50)

115 (71–158)

153 (102–205)

149 (46–251)

163 (21–305)

153 (55–251)

GPT (U/l, normal range: <50)

75 (52–98)

84 (57–111)

77 (40–115)

65 (8–120)

116 (4–228)

C-Reactive Protein (mg/l, normal range:<5)

182 (145–219)

178 (130–226)

187 (90–284)

178 (25–331)

163 (74–225)